尊龙凯时人生就是搏·(中国区)官方网站

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025

NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS

NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED HOLDERS

2025 INTERIM REPORT

VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN THE PHASE I CLINICAL TRIAL OF LM-350 "CDH17 ADC" IN AUSTRALIA

VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN THE PHASE I CLINICAL TRIAL OF LM-2417 "NaPi2b/4-1BB BISPECIFIC ANTIBODY" IN CHINA

VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF TQF3250 CAPSULES "GLP-1 RECEPTOR AGONIST" ACCEPTED BY NMPA

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025